biote Corp.
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
BTMD$1.08-2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity (Deficit)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2023 | 34,254,883 | $3 | 28,819,066 | $3 | $— | $(29,391) | $(12) | $— | $(29,397) | $(7,149) | $(36,546) |
| Distributions | — | — | — | — | — | — | — | — | — | (4,744) | (4,744) |
| Net income (loss) | — | — | — | — | — | 3,157 | — | — | 3,157 | (3,111) | 46 |
| Other comprehensive income | — | — | — | — | — | — | (18) | — | (18) | (4) | (22) |
| Share-based compensation | — | — | — | — | — | 8,735 | — | — | 8,735 | — | 8,735 |
| Vesting of RSUs | 444,783 | — | — | — | — | (17,959) | (7) | — | (17,966) | 17,966 | — |
| Issuance of stock under purchase plans | 63,413 | — | — | — | — | (836) | — | — | (836) | 1,118 | 282 |
| Exercise of stock options | 556,515 | — | — | — | — | (2,140) | (1) | — | (2,141) | 4,531 | 2,390 |
| Common stock repurchased | (996,964) | — | — | — | — | — | — | (5,599) | (5,599) | — | (5,599) |
| Shares issued in connection with acquisition | 291,829 | — | — | — | — | 1,146 | — | — | 1,146 | 695 | 1,841 |
| Exchanges of Class V voting stock | 1,946,408 | — | (1,946,408) | — | — | 3,656 | 2 | — | 3,658 | (3,658) | — |
| Legal Settlement - Repurchase of Shares | (5,075,090) | — | (21,651,005) | (2) | — | (126,498) | 1 | (1) | (126,500) | (1,916) | (128,416) |
| Legal Settlement - Liabilities | — | — | — | — | — | 59,074 | — | — | 59,074 | — | 59,074 |
| TRA liability | — | — | — | — | — | 759 | — | — | 759 | — | 759 |
| Balance at December 31, 2024 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(100,297) | $(35) | $(5,600) | $(105,928) | $3,728 | $(102,200) |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
| Total | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Attributable to · controlling · Stockholders’ | |||||||||||||||
| Shares · Amount · Shares · Amount · Capital · Deficit · Loss · biote Corp. · Interest · Deficit | |||||||||||||||
| Balance at December 31, 2022 | 9,655,387 | 1 | 48,565,824 | 5 | — | (44,460) | (5) | (44,459) | (13,815) | (58,274) | |||||
| Distributions | — | — | — | — | — | — | — | — | (8,694) | (8,694) | |||||
| Net income (loss) | — | — | — | — | — | 3,316 | — | 3,316 | (6,121) | (2,805) | |||||
| Other comprehensive income | — | — | — | — | — | — | 9 | 9 | 10 | 19 | |||||
| Share-based compensation | — | — | — | — | — | 9,057 | — | 9,057 | — | 9,057 | |||||
| Vesting of RSUs | 1,250,512 | — | — | — | — | (3,928) | (6) | (3,934) | 3,934 | — | |||||
| Issuance of stock under purchase plans | 33,704 | (23) | — | (23) | 167 | 144 | |||||||||
| Settlement of warrants | 3,088,473 | — | — | — | — | 15,986 | (1) | 15,985 | 1,530 | 17,515 | |||||
| Exercise of stock options | 105,049 | — | — | — | — | 2,043 | (3) | 2,040 | (1,620) | 420 | |||||
| Litigation settlement | 375,000 | — | — | — | — | 1,199 | — | 1,199 | — | 1,199 | |||||
| Exchanges of Class V voting stock | 19,746,758 | 2 | (19,746,758) | (2) | — | (17,455) | (6) | (17,461) | 17,460 | (1) | |||||
| TRA liability | — | — | — | — | — | 4,874 | — | 4,874 | — | 4,874 | |||||
| Balance at December 31, 2023 | 34,254,883 | 3 | 28,819,066 | 3 | — | (29,391) | (12) | (29,397) | (7,149) | (36,546) | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.